cabinet ophtalmo bordeaux Prendre rendez-vous Book an appointment

Publications


In french In english

[27/09/2018] EURETINA 2018 Communication

S. Baillif, L. Kodjikian, E. Fourmaux, F. Coscas, C. Faure, S. Cohen, M. Weber FRANCE
A real-world study to monitor wet age-related macular degeneration patients treated with intravitreal aflibercept: 12-month outcomes of RAINBOW stratified by treatment regimen
Detail

[14/02/2018] Cataract Avoidance with Proton Therapy in Ocular Melanomas

Cataract Avoidance with Proton Therapy in Ocular Melanomas
Juliette ThariatSophie JacobJean-Pierre CaujolleCelia MaschiStéphanie BaillifGaelle AngellierThibaud MathisLaurence Rosier; Adela CarnicerJoel HéraultJulia Salleron
IOVS investigative ophthalmology visual science october 2017 Vol.58,No.12
Detail

[10/05/2017] Poster ARVO 2017 Baltimore USA

Real-world outcomes with ranibizumab 0.5 mg in treatment-naïve French patients with visual impairment due to diabetic macular edema: 12-month results from the ETOILE study
Eric Fourmaux, Amélie Lecleire-Collet,Corinne Dot,Marie-Laure Le Lez,Stéphanie Baillif,Ali Erginay,Eric Souied,Philippe Gain,Laetitia Finzi,Laurent Kodjikian
 
Detail

[07/05/2017] Poster ARVO 2017 Batimore USA

Evaluation of time-to-recurrence of disease activity in treatment-naïve patients with neovascular age-related macular degeneration after ranibizumab treatment: 12-month analysis from the ORACLE study
Maddalena Quaranta,François Devin,Gabriel Quentel,Joël Uzzan, Eric Fourmaux, Laurent Castelnovo,Wilfried Roquet,Catherine Francais-Maury,Sam Razavi,Nathalie San Nicolas

 
Detail

[10/02/2017] Poster ASCRS Maastricht

Poster presented in ASCRS ( American Society of Cataract and Refractiv Surgery ) Congress Maastricht Netherlands
Multicenter evaluation of Time, Operational and Economic Efficiencies of a New Pre-loaded IOL delivery system vs manual IOL delivery . Mendicute J1, Júlvezm L2, Schweitzer C3, Vélasque L4, Martinez A5
1Hospital Universitario Donostia Servicio de Oftalmología. 2Hospital Universitario Miguel Servet Servicio de Oftalmología . 3Service d’Ophtalmologie du Pr KOROBELNIK – Hôpital Pellegrin. 4Centre Retine Gallien Bordeaux. 5Alcon Laboratories, Inc., Fort Worth, TX
 
Detail

[23/09/2016] Visual Outcomes of Parapapillary Uveal Melanomas following Proton beam Therapy


Juliette Thariat, MD, PhD, Jean-Daniel Grange, MD, Carlo Mosci, MD, Laurence Rosier, MD, Celia Maschi, MD, Francesco Lanza, MD, Anh Minh Nguyen, MD, Franck Jaspart, MD, Franck Bacin, MD, PhD, Nicolas Bonnin, MD, David Gaucher, MD, Wolfgang Sauerwein, MD, PhD, Gaelle Angellier, PhD, Joel Hérault, P, Jean-Pierre Caujolle
Radiat Oncol Biol Phys. 2016;95(1) : 328-35 
Detail

[04/05/2016] Poster ARVO 2016 :

Time to recurrence in neovascular age-related macular degeneration after ranibizumab treatment: baseline characteristics of treatment-naïve patients enrolled in the ORACLE study
Francois Devin, Eric Fourmaux, Gabriel Quentel, Joel Uzan, Maddalena Quaranta El-Maftouhi, Catherine Francais-Maury, Wilfried Roquet, Laurent Castelnovo, Sam Razavi, Laetitia Finzi
Invest. Ophthalmol.Vis. Sci.. 2016, Vol.57, 3353. doi:
 
Detail

[03/05/2016] Poster ARVO 2016 :

Real Life Use of Intravitreal Aflibercept In FraNce: oBservatiOnal study in Wet AMD: the RAINBOW study
Hassiba Oubraham-Mebroukine, Céline Faure, Florence Coscas, Thi Ha Chau Tran, Benedicte Briend-Joulain, Laurent Velasque,
Isabelle Aubry, Michel Weber, Salomon-Yves Cohen
Invest. Ophthalmol. Vis. Sci.. 2016; 57(12):524. doi:
Detail

[16/11/2015] Corrigendum to Strategy for the Management of Diabetic Macular Edema

The European Vitreo-Retinal Society Macular Edema Study".

Adelman RAParnes AJMichalewska ZParolini BBoscher CDucournau DEVRS Macular Edema Study Group.

Biomed Res Int. 2015;2015:694902. doi: 10.1155/2015/694902. Epub 2015 Dec 20.


Detail

[06/11/2015] Intravitreal ranibizumab combined with verteporfin photodynamic therapy in the management of wet age-related macular degeneration in routine clinical practice in France: the AURORE study.

Franck Rumen, Dominique Pawlak, Christian Malbrel, Wilfred Roquet, Joël Uzzan, Alain Chouquet, Christian Delhay, Jean-Claude Quintyn, Eric Fourmaux, Alain Deudon-Combe, Walid Michel Haddad, David Sayag, Elizabeth Latour†, Laetitia Finzi.
Detail

[01/09/2014] Clinical variables associated with failure of retinal detachment repair: the European vitreo-retinal society retinal detachment study report number 4.

Adelman RA, Parnes AJ, Michalewska Z, Ducournau D; European Vitreo-Retinal Society (EVRS) Retinal Detachment Study Group. Ophthalmology. 2014 Sep;121(9):1715-9. doi: 10.1016/j.ophtha.2014.03.012. Epub 2014 Apr 22.
Detail

[03/05/2014] Poster ARVO 2014 :

RAVE  2 Study : Two years treatment follow up with intravitreal ranibizumab (Lucentis®) and verteporfin PDTRF  combination therapy at month 2 for neovascular age-related macular degeneration (AMD)
M. Dominguez – E. Fourmaux - L. Rosier - L. Velasque    Centre Rétine Gallien  Bordeaux - France
Invest. Ophthalmol. Vis. Sci.. 2014; 55(13):3961. doi:
 
Detail

[07/09/2013] Comparison of clinical efficacy: Nd:YAG laser rates after implantation of AcrySof® SN60WF, Akreos® AO-MI60 and Hoya® YA-60BB.

Bourdiol Ducasse AM, Guerzider V, Velasque L, Dominguez M, Lafuma A, Robert J. J Fr Ophtalmol. 2013 Sep;36(7):575-82


Detail

[02/09/2013] Strategy for the management of complex retinal detachments: the European vitreo-retinal society retinal detachment study report 2.

Adelman RA, Parnes AJ, Sipperley JO, Ducournau D; European Vitreo-Retinal Society (EVRS) Retinal Detachment Study Group. Ophthalmology. 2013 Sep;120(9):1809-13. doi: 10.1016/j.ophtha.2013.01.056. Epub 2013 Apr 17.
Detail

[01/09/2013] Strategy for the management of uncomplicated retinal detachments: the European vitreo-retinal society retinal detachment study report 1.

Adelman RA, Parnes AJ, Ducournau D; European Vitreo-Retinal Society (EVRS) Retinal Detachment Study Group. Ophthalmology. 2013 Sep;120(9):1804-8. doi: 10.1016/j.ophtha.2013.01.070. Epub 2013 Apr 16.
Detail

[05/05/2012] Poster ARVO 2012 :

One year’s treatment with intravitreal ranibizumab (Lucentis®) and verteporfin PDT  combination therapy at month 2 for neovascular age-related macular degeneration (AMD)
E. Fourmaux - M. Dominguez - L. Rosier - L. Velasque  Rétine Gallien  Bordeaux - France
Detail

[06/09/2008] 8th European VitreoRetinal Society congress, Prague

My way in…Pseudophakic retinal detachment surgery  -  M. Dominguez, MD
Detail

[01/10/2006] BEST disease. Ophthalmoscopic and OCT views

Rosier L, Velasque L, Dominguez M.
J Fr Ophtalmol. 2006 Oct;29(8):959.


Detail

[01/11/2005] Spontaneous retrohyaloid hemorrhage treated with YAG laser].

Velasque L, Dominguez M, Rosier L.
J Fr Ophtalmol. 2005 Nov;28(9):1007.


Detail

[25/09/2005] Complications and lack of benefit after transpupillary thermotherapy for occult choroidal neovascularization: 1-year results

Rougier MB, Francois L, Fourmaux E, Isber R, Colin J, Korobelnik JF. 
Retina. 2005 Sep;25(6):784-8.
 
Detail

[19/04/2004] Laser photocoagulation for choroidal neovascular membrane associated with optic disc

Delyfer MN, Rougier MB, Fourmaux E, Cousin P, Korobelnik JF.    Ophthalmol Scand. 2004 Apr;82(2):236-8.
Detail

[30/06/1999] Results of proton therapy of uveal melanomas treated in Nice.

Courdi A, Caujolle JP, Grange JD, Diallo-Rosier LR, Sahel J.  Int J radiat oncol Biol Phys. 1999;45:5-11
Detail

[30/06/1994] Technical considerations about protontherapy and visual conservation for uveal melanomas: The experience of the SERAG.

Chauvel P,Brassart N,Herault J,Courdi A,CaujolleJP,Grange JD, Mouries O, Diallo-Rosier L, Mosci C, Polizzi A, Porta A, Menci E, Bornfeld N, Friedrichs W, Sahel J, Bacin F, Ge ́rard JP, Sauerwein W, Scolaro T, Carrie C, Kantor G, Rozan R, Teissier T, Bensadoun RJ, Lagrange JL, Demard F. Technical considerations about protontherapy and visual conservation for uveal melanomas: The experience of the SERAG. In: Frezzotti R, Balestrazzi E, Falco L, Esente S, editors. International Symposium on Intraocular and Epibulbar Tumors. Bologna: Monduzzi Editore; 1994. p. 99– 103.
Detail